Bluejay Diagnostics inks US-manufacturing partnership to support Symphony rollout
Bluejay Diagnostics announced a strategic alliance with Argonaut Manufacturing Services to build US-based manufacturing for its Symphony platform, aiming to improve supply-chain resilience and broaden US distribution as it advances the SYMON clinical program. The partnership could bolster near-term milestones and facilitate a potential FDA 510(k) submission, though the Symphony IL-6 test remains investigational in the US.
View signal analysis